Advanced therapeutic endoscopy procedures are of increasing importance to provide minimal invasive treatment for GI diseases. The Centre Hospitalier de l'Université de Montréal as tertiary university center is dedicated to increase the availability of therapeutic endoscopy procedures for our population in Montreal and Quebec. Advanced endotherapeutic endoscopy can replace surgery for treatment of benign and malign GI diseases and the aim of this registry-based study is to improve quality related to advanced endotherapeutic endoscopy, as it will provide quantitative means to assess advanced endotherapeutic practice and may identify practices of low quality (possible intervention) or high quality (desired).
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Assess the incidence of overall severe complications following the procedure
Timeframe: 14 days
Assess the rate of completeness of neoplastic tissue resection
Timeframe: 6-18 months
Severe bleeding complications
Timeframe: 14 days
Assess the presence of perforation at resection site
Timeframe: 6-18 months
Assess the number of patients with post-polypectomy syndrome
Timeframe: 6-18 months
Assess the efficacy of submucosal injectate
Timeframe: 6-18 months
Assess the number of patients with intraprocedural bleeding
Timeframe: 6-18 months
Daniel von Renteln, MD, PhD
Assess the number of patients with the need for surgical resection
Timeframe: 6-18 months
Technical skill of the endoscopist
Timeframe: 6-18 months
En-bloc resection rate
Timeframe: 6-18 months
R0 resection rate
Timeframe: 6-18 months
Local recurrence rate
Timeframe: 6-18 months
Distant metastasis rate
Timeframe: 6-18 months
Lymph node involvement rate
Timeframe: 6-18 months
Disease progression
Timeframe: 6-18 months
Progression-free survival (PFS)
Timeframe: 6-18 months
Cancer-related mortality
Timeframe: 6-18 months
All-cause mortality
Timeframe: 6-18 months
Time to recurrence
Timeframe: 6-18 months
Quality of life (QoL) score
Timeframe: 6-18 months